The dynamic changes in FDX1 and LIAS reflect the adaptive response and regulatory mechanisms of HSCs when faced with DATs treatment, providing new insights into the application of copper death in the treatment of liver fibrosis. The gene discussed is FDX1; the disease is Hepatic fibrosis.